Loading...

David Alan Ginsberg, MD

TitleProfessor of Clinical Urology
InstitutionUniversity of Southern California
DepartmentUrology
AddressNOR 7416
Health Sciences Campus
Los Angeles CA 90089-9178
Phone+1 323 865 3700
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    David Alan Ginsberg, MD is a native Southern Californian who earned his bachelor’s degree at the University of California at Berkeley. He subsequently returned to Los Angeles where he completed medical school and urology residency at the Keck School of Medicine of USC and its affiliated hospital, Los Angeles County Medical Center. Dr. Ginsberg finished his training at UCLA where he completed a fellowship focused on female urology, voiding dysfunction and urologic reconstruction.

    Dr. Ginsberg is board certified in Urology and Female Pelvic Medicine & Reconstructive Urology and is also a Fellow of the American College of Surgeons. In addition to his faculty appointment at USC, Dr. Ginsberg is Chief of Urology at Rancho Los Amigo National Rehabilitation Center. Dr. Ginsberg’s clinical practice is focused on female pelvic medicine, which includes urinary incontinence and pelvic organ prolapse, neurogenic bladder and male voiding dysfunction.

    Dr. Ginsberg’s present research interests focus on lower urinary tract reconstruction in spinal cord injury patients, urologic applications of botulinum toxin and long-term follow-up issues for patients with neurogenic bladder. Dr. Ginsberg is the author or co-author of over 70 peer-reviewed articles, numerous book chapters and is a regular reviewer for journals such as Journal of Urology, Urology, Neurourology & Urodynamics and Neurosurgery. He has held several visiting professorships and has been invited to lecture on multiple occasions throughout the United States and the world. He is on the urological editorial board for Medscape and was a member of the American Urological Association/American Board of Urology Exam Committee. Dr. Ginsberg is a present member of the American Urological Association Stress Incontinence Guidelines Panel.


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kreydin E, Welk B, Chung D, Clemens Q, Yang C, Danforth T, Gousse A, Kielb S, Kraus S, Mangera A, Reid S, Szell N, Cruz F, Chartier-Kastler E, Ginsberg D. Surveillance and management of urologic complications after spinal cord injury. World J Urol. 2018 May 29. PMID: 29845320.
      View in: PubMed
    2. Ghodoussipour SB, Gould D, Lifton J, Badash I, Krug A, Miranda G, Loh-Doyle J, Carey J, Djaladat H, Doumanian L, Ginsberg D. Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay. J Plast Reconstr Aesthet Surg. 2018 May; 71(5):712-718. PMID: 29284566.
      View in: PubMed
    3. Rosenberg S, Miranda G, Ginsberg D. Neobladder-Vaginal fistula: The University of Southern California experience. Neurourol Urodyn. 2018 Apr; 37(4):1380-1385. PMID: 29140545.
      View in: PubMed
    4. Drake MJ, Nitti VW, Ginsberg D, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int. 2017 11; 120(5):611-622. PMID: 28670786.
      View in: PubMed
    5. Kobashi KC, Albo ME, Dmochowski RR, Ginsberg D, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE. Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline. J Urol. 2017 Oct; 198(4):875-883. PMID: 28625508.
      View in: PubMed
    6. Ginsberg D, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW. Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder. J Urol. 2017 Oct; 198(4):897-904. PMID: 28536084.
      View in: PubMed
    7. Ginsberg D. Editorial Comment. J Urol. 2017 Jul; 198(1):210. PMID: 28396059.
      View in: PubMed
    8. Gao Y, Danforth T, Ginsberg D. Urologic Management and Complications in Spinal Cord Injury Patients: A 40- to 50-year Follow-up Study. Urology. 2017 Jun; 104:52-58. PMID: 28322903.
      View in: PubMed
    9. Ginsberg D. OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro. J Urol. 2017 Jan; 197(1):11-13. PMID: 27742453.
      View in: PubMed
    10. Rac G, Younger A, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, MacLachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner ES. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160. PMID: 27460448.
      View in: PubMed
    11. Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P, De Ridder D, Jenkins B, Magyar A, Chapple C. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800. PMID: 27038769.
      View in: PubMed
    12. McCoy O, Vaughan T, Nickles SW, Ashley M, MacLachlan LS, Ginsberg D, Rovner E. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9. PMID: 26997314.
      View in: PubMed
    13. Freemantle N, Ginsberg D, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J. Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison. BMJ Open. 2016 Feb 23; 6(2):e009122. PMID: 26908514; PMCID: PMC4769403.
    14. Younger A, Rac G, Clemens JQ, Kobashi K, Khan A, Nitti V, Jacobs I, Lemack GE, Brown ET, Dmochowski R, Maclachlan L, Mourtzinos A, Ginsberg D, Koski M, Rames R, Rovner E. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51. PMID: 26845051.
      View in: PubMed
    15. Ginsberg D, Schneider LK, Watanabe TK. Improving Outcomes in Patients With Refractory Idiopathic and Neurogenic Detrusor Overactivity: Management Strategies. Arch Phys Med Rehabil. 2015 Sep; 96(9 Suppl):S341-57.e1. PMID: 26318392.
      View in: PubMed
    16. Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G, Salibian S, Aron M, Ginsberg D, Daneshmand S, Desai M, Gill IS. Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life. Eur Urol. 2016 Feb; 69(2):247-53. PMID: 26164417.
      View in: PubMed
    17. Vainrib M, Reyblat P, Ginsberg D. Outcomes of Male Sling Mesh Kit Placement in Patients with Neuropathic Stress Urinary Incontinence: A Single Institution Experience. Urol Int. 2015; 95(4):406-10. PMID: 25969383.
      View in: PubMed
    18. Ginsberg D. Editorial comment. J Urol. 2015 Jun; 193(6):2094; discussion 2094. PMID: 25797541.
      View in: PubMed
    19. Goldmark E, Niver B, Ginsberg D. Neurogenic bladder: from diagnosis to management. Curr Urol Rep. 2014 Oct; 15(10):448. PMID: 25118855.
      View in: PubMed
    20. Vainrib M, Reyblat P, Ginsberg D. Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury. Urology. 2014 Oct; 84(4):940-5. PMID: 25102789.
      View in: PubMed
    21. Danforth TL, Aron M, Ginsberg D. Robotic sacrocolpopexy. Indian J Urol. 2014 Jul; 30(3):318-25. PMID: 25097320; PMCID: PMC4120221.
    22. Danforth TL, Ginsberg D. Neurogenic lower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Urol Clin North Am. 2014 Aug; 41(3):445-52, ix. PMID: 25063601.
      View in: PubMed
    23. Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014 Mar; 113(3):484-91. PMID: 24528881.
      View in: PubMed
    24. Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, Sievert KD, Brin MF, Jenkins B, Thompson C, Lam W, Heesakkers J, Haag-Molkenteller C. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology. Adv Ther. 2013 Sep; 30(9):819-33. PMID: 24072665; PMCID: PMC3824824.
    25. Ginsberg D, Schneider T, Kelleher C, Van Kerrebroeck P, Swift S, Creanga D, Martire DL. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder. BJU Int. 2013 Aug; 112(3):373-85. PMID: 23826844.
      View in: PubMed
    26. Vainrib M, Simma-Chiang V, Boyd SD, Ginsberg D. Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion. Neurourol Urodyn. 2013 Sep; 32(7):1010-3. PMID: 23595916.
      View in: PubMed
    27. Ginsberg D. Optimizing therapy and management of neurogenic bladder. Am J Manag Care. 2013; 19(10 Suppl):s197-204. PMID: 24495241.
      View in: PubMed
    28. Ginsberg D. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care. 2013; 19(10 Suppl):s191-6. PMID: 24495240.
      View in: PubMed
    29. Vainrib M, Reyblat P, Ginsberg D. Differences in urodynamic study variables in adult patients with neurogenic bladder and myelomeningocele before and after augmentation enterocystoplasty. Neurourol Urodyn. 2013 Mar; 32(3):250-3. PMID: 22965686.
      View in: PubMed
    30. Ginsberg D. Editorial comment. Urology. 2012 Aug; 80(2):464-5. PMID: 22704176.
      View in: PubMed
    31. Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012 Jun; 187(6):2131-9. PMID: 22503020.
      View in: PubMed
    32. Simma-Chiang V, Ginsberg D, Teruya KK, Boyd SD. Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience. Urology. 2012 Jun; 79(6):1397-401. PMID: 22449453.
      View in: PubMed
    33. Fowler CJ, Auerbach S, Ginsberg D, Hale D, Radziszewski P, Rechberger T, Patel VD, Zhou J, Thompson C, Kowalski JW. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial. Eur Urol. 2012 Jul; 62(1):148-57. PMID: 22464310.
      View in: PubMed
    34. Ginsberg D. Bladder acontractility: detrusor myoplasty and other options. Nat Rev Urol. 2011 Apr; 8(4):185-6. PMID: 21475331.
      View in: PubMed
    35. Ginsberg D, Oefelein MG, Ellsworth PI. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials. Neurourol Urodyn. 2011 Apr; 30(4):563-7. PMID: 21268101.
      View in: PubMed
    36. Reyblat P, Ginsberg D. Augmentation enterocystoplasty in overactive bladder: is there still a role? Curr Urol Rep. 2010 Nov; 11(6):432-9. PMID: 20734172.
      View in: PubMed
    37. MacDiarmid SA, Ellsworth PI, Ginsberg D, Oefelein MG, Sussman DO. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder. Urology. 2011 Jan; 77(1):24-9. PMID: 20970833.
      View in: PubMed
    38. Reyblat P, Ginsberg D. Editorial comment. Urology. 2010 Jun; 75(6):1308-9; author reply 1309. PMID: 20513491.
      View in: PubMed
    39. Ginsberg D. Indications and complications of cystectomy in patients with neurogenic bladder. J Urol. 2010 Jul; 184(1):10-1. PMID: 20478604.
      View in: PubMed
    40. Ginsberg D. Editorial comment. Urology. 2009 Oct; 74(4):775; author reply 776-7. PMID: 19800496.
      View in: PubMed
    41. Reyblat P, Chan KG, Josephson DY, Stein JP, Freeman JA, Grossfeld GD, Esrig D, Ginsberg D. Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients. World J Urol. 2009 Feb; 27(1):63-8. PMID: 19020878.
      View in: PubMed
    42. Reyblat P, Ginsberg D. Augmentation cystoplasty: what are the indications? Curr Urol Rep. 2008 Nov; 9(6):452-8. PMID: 18947509.
      View in: PubMed
    43. Yang J, Liu L, Xie HW, Ginsberg D. Chinese urologists' practice patterns of diagnosing and treating chronic prostatitis: a questionnaire survey. Urology. 2008 Sep; 72(3):548-51. PMID: 18597833.
      View in: PubMed
    44. Liu LF, Yang JR, Ginsberg D, Xie HW, Rao JM, Wang L, Yin Z, He Q, Yang TB. Factors influencing the diagnosis and treatment of chronic prostatitis among urologists in China. Asian J Androl. 2008 Jul; 10(4):675-81. PMID: 18478166.
      View in: PubMed
    45. Ginsberg D, Phillips SE, Wallace J, Josephson KL. Evaluating and managing constipation in the elderly. Urol Nurs. 2007 Jun; 27(3):191-200, 212; quiz 201. PMID: 17674594.
      View in: PubMed
    46. Ginsberg D. Management of the neurogenic bladder in the female patient. Curr Urol Rep. 2006 Sep; 7(5):423-8. PMID: 16959182.
      View in: PubMed
    47. Quek ML, Barry P, Stein JP, Lieskovsky G, Ginsberg D. Combined radical prostatectomy and bladder augmentation for concomitant prostate cancer and detrusor instability. Urology. 2005 May; 65(5):964-7. PMID: 15882732.
      View in: PubMed
    48. Shpall AI, Ginsberg D. Bladder neck closure with lower urinary tract reconstruction: technique and long-term followup. J Urol. 2004 Dec; 172(6 Pt 1):2296-9. PMID: 15538252.
      View in: PubMed
    49. Quek ML, Ginsberg D, Wilson S, Skinner EC, Stein JP, Skinner DG. Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. J Urol. 2004 Jul; 172(1):219-21. PMID: 15201778.
      View in: PubMed
    50. Wilson S, Quek ML, Ginsberg D. Transurethral injection of bulking agents for stress urinary incontinence following orthotopic neobladder reconstruction in women. J Urol. 2004 Jul; 172(1):244-6. PMID: 15201784.
      View in: PubMed
    51. Tabibian L, Ginsberg D. Thrombosed urethral hemangioma. J Urol. 2003 Nov; 170(5):1942. PMID: 14532816.
      View in: PubMed
    52. Ginsberg D. Vaginal vault prolapse: evaluation and repair. Curr Urol Rep. 2003 Oct; 4(5):404-8. PMID: 14499066.
      View in: PubMed
    53. Shpall AI, Varpetian A, Ginsberg D. Urinary retention in a patient with West Nile virus. Urology. 2003 Jun; 61(6):1259. PMID: 12809920.
      View in: PubMed
    54. Zommick JN, Simoneau AR, Skinner DG, Ginsberg D. Continent lower urinary tract reconstruction in the cervical spinal cord injured population. J Urol. 2003 Jun; 169(6):2184-7. PMID: 12771745.
      View in: PubMed
    55. Quek ML, Ginsberg D. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol. 2003 Jan; 169(1):195-8. PMID: 12478134.
      View in: PubMed
    56. Daneshmand S, Ginsberg D, Bennet JK, Foote J, Killorin W, Rozas KP, Green BG. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol. 2003 Jan; 169(1):199-202. PMID: 12478135.
      View in: PubMed
    57. Stein JP, Ginsberg D, Skinner DG. Indications and technique of the orthotopic neobladder in women. Urol Clin North Am. 2002 Aug; 29(3):725-34, xi. PMID: 12476536.
      View in: PubMed
    58. Ginsberg D, Boyd SD. Permanent urinary retention after transurethral injection of collagen. J Urol. 2002 Feb; 167(2 Pt 1):648. PMID: 11792941.
      View in: PubMed